PSMB7
Proteasome subunit beta type-7
Also known as: PSB7_HUMAN, Z
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99436
- Gene
- PSMB7
- Ensembl
- ENSG00000136930
- Chromosome
- 9
- Canonical length
- 277 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Primary cilium,Cytosol
OverviewNCBI Gene
The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. The encoded protein is a member of the proteasome B-type family, also known as the T1B family, and is a 20S core beta subunit in the proteasome. Expression of this catalytic subunit is downregulated by gamma interferon, and proteolytic processing is required to generate a mature subunit. A pseudogene of this gene is located on the long arm of chromosome 14. [provided by RefSeq, Jul 2012]
Canonical amino-acid sequenceUniProt
277 residues, UniProt reviewed canonical sequence.
>Q99436|PSMB7
1 MAAVSVYAPP VGGFSFDNCR RNAVLEADFA KRGYKLPKVR KTGTTIAGVV YKDGIVLGAD
61 TRATEGMVVA DKNCSKIHFI SPNIYCCGAG TAADTDMTTQ LISSNLELHS LSTGRLPRVV
121 TANRMLKQML FRYQGYIGAA LVLGGVDVTG PHLYSIYPHG STDKLPYVTM GSGSLAAMAV
181 FEDKFRPDME EEEAKNLVSE AIAAGIFNDL GSGSNIDLCV ISKNKLDFLR PYTVPNKKGT
241 RLGRYRCEKG TTAVLTEKIT PLEIEVLEET VQTMDTSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSMB7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 266 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 266 nTPM
- liver: 208 nTPM
- heart muscle: 201 nTPM
- tongue: 192 nTPM
- bone marrow: 179 nTPM
- adrenal gland: 171 nTPM
Single-cell type
- late primary spermatocytes: 720 nCPM
- late spermatids: 685 nCPM
- syncytiotrophoblasts: 597 nCPM
- oocytes: 585 nCPM
- cytotrophoblasts: 552 nCPM
- esophageal apical cells: 517 nCPM
Immune cell
- total PBMC: 265 nTPM
- T-reg: 227 nTPM
- myeloid DC: 221 nTPM
- intermediate monocyte: 212 nTPM
- non-classical monocyte: 208 nTPM
- classical monocyte: 202 nTPM
Brain region
- midbrain: 133 nTPM
- thalamus: 130 nTPM
- pons: 130 nTPM
- medulla oblongata: 128 nTPM
- hypothalamus: 127 nTPM
- basal ganglia: 122 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.89
- gnomAD missense Z
- 0.85
- DepMap mean gene effect
- -1.31
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PSMB7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSMB7 as an antibody target. Whether an autoantibody or antibody against PSMB7 could matter depends on whether native PSMB7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSMB7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PSMB7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...